Novartis AG (NVS)
130.59
-0.42
(-0.32%)
USD |
NYSE |
Dec 10, 12:20
Novartis Profit Margin (Quarterly): 28.26% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Avidity Biosciences, Inc. | -1.40K% |
| Monte Rosa Therapeutics, Inc. | -212.1% |
| Tourmaline Bio, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 33.87% |
| Return on Assets | 13.81% |
| Return on Invested Capital | 19.37% |
| Gross Profit Margin (Quarterly) | 74.58% |
| Operating Margin (Quarterly) | 30.24% |
| Return on Net Operating Assets | 18.18% |